{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T10:13:54Z","timestamp":1775211234224,"version":"3.50.1"},"reference-count":38,"publisher":"Sociedade Brasileira de Cardiologia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,8]]},"DOI":"10.36660\/abc.20201361","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T18:18:27Z","timestamp":1639160307000},"source":"Crossref","is-referenced-by-count":2,"title":["Qual Deve Ser o Tratamento de Primeira Linha para o Fechamento de Persist\u00eancia de Canal Arterial Hemodinamicamente Significativo em Beb\u00eas Prematuros?"],"prefix":"10.36660","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9409-185X","authenticated-orcid":false,"given":"Ufuk","family":"Cakir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuneyt","family":"Tayman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22636","reference":[{"issue":"3","key":"key20211210131721_B1","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jpeds.2013.11.008","article-title":"Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial","volume":"164","author":"Oncel","year":"2014","unstructured":"1. Oncel MY, Yurttutan S, Erdeve O, Uras N, Altug N, Oguz SS, et al. Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial. J Pediatr. 2014;164(3):510-4.e1.","journal-title":"J Pediatr"},{"issue":"2","key":"key20211210131721_B2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40272-019-00331-z","article-title":"Efficacy and Safety of Oral Paracetamol vs. Oral Ibuprofen in the Treatment of Symptomatic Patent Ductus Arteriosus in Premature Infants","volume":"21","author":"Karabulut","year":"2019","unstructured":"2. Karabulut B, Paytoncu S. Efficacy and Safety of Oral Paracetamol vs. Oral Ibuprofen in the Treatment of Symptomatic Patent Ductus Arteriosus in Premature Infants. Paediatr Drugs. 2019;21(2):113-21.","journal-title":"Paediatr Drugs"},{"issue":"26","key":"key20211210131721_B3","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1056\/NEJM200106283442602","article-title":"Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants","volume":"344","author":"Schmidt","year":"2001","unstructured":"3. Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S, et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med. 2001;344(26):1966-72.","journal-title":"N Engl J Med"},{"issue":"6","key":"key20211210131721_B4","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1542\/peds.2004-1178","article-title":"Prophylactic ibuprofen for the prevention of intraventricular hemorrhage among preterm infants: a multicenter, randomized study","volume":"115","author":"Dani","year":"2005","unstructured":"4. Dani C, Bertini G, Pezzati M, Poggi C, Guerrini P, Martano C, et al. Prophylactic ibuprofen for the prevention of intraventricular hemorrhage among preterm infants: a multicenter, randomized study. Pediatrics. 2005;115(6):1529-35.","journal-title":"Pediatrics"},{"issue":"6","key":"key20211210131721_B5","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.jpeds.2011.12.031","article-title":"Timing of patent ductus arteriosus treatment and respiratory outcome in premature infants: a double-blind randomized controlled trial","volume":"160","author":"Sosenko","year":"2012","unstructured":"5. Sosenko IR, Fajardo MF, Claure N, Bancalari E. Timing of patent ductus arteriosus treatment and respiratory outcome in premature infants: a double-blind randomized controlled trial. J Pediatr. 2012;160(6):929-35.e1.","journal-title":"J Pediatr"},{"issue":"2","key":"key20211210131721_B6","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/00008480-200404000-00005","article-title":"Patency of the ductus arteriosus in the premature infant: is it pathologic? Should it be treated?","volume":"16","author":"Laughon","year":"2004","unstructured":"6. Laughon MM, Simmons MA, Bose CL. Patency of the ductus arteriosus in the premature infant: is it pathologic? Should it be treated? Curr Opin Pediatr. 2004;16(2):146-51.","journal-title":"Curr Opin Pediatr"},{"issue":"7","key":"key20211210131721_B7","article-title":"Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants","volume":"2010","author":"Fowlie","year":"2010","unstructured":"7. Fowlie PW, Davis PG, McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev. 2010;2010(7):CD000174.","journal-title":"Cochrane Database Syst Rev"},{"key":"key20211210131721_B8","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.5152\/TurkPediatriArs.2018.01808","article-title":"Turkish Neonatal Society guideline on the management of patent ductus arteriosus in preterm infants","volume":"53","author":"K\u00f6ksal","year":"2018","unstructured":"8. K\u00f6ksal N, Ayg\u00fcn C, Uras N. Turkish Neonatal Society guideline on the management of patent ductus arteriosus in preterm infants. Turk Pediatri Ars. 2018;53(Suppl 1):S76\u201387.","journal-title":"Turk Pediatri Ars"},{"key":"key20211210131721_B9","article-title":"Efficacy and safety of intravenous paracetamol in comparison to ibuprofen for the treatment of patent ductus arteriosus in preterm infants: study protocol for a randomized control trial","volume":"17","author":"Sosenko","year":"2016","unstructured":"9. Sosenko C, Poggi C, Mosca F, Schena F, Lista G, Ramenghi L, et al. Efficacy and safety of intravenous paracetamol in comparison to ibuprofen for the treatment of patent ductus arteriosus in preterm infants: study protocol for a randomized control trial. Trials. 2016;17:182.","journal-title":"Trials"},{"issue":"11","key":"key20211210131721_B10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077888","article-title":"Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial","volume":"8","author":"Dang","year":"2013","unstructured":"10. Dang D, Wang D, Zhang C, Zhou W, Zhou Q, Wu H. Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial. PLoS One. 2013;8(11):e77888.","journal-title":"PLoS One"},{"issue":"21","key":"key20211210131721_B11","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1080\/14767058.2018.1470235","article-title":"Efficacy and safety of oral paracetamol versus oral ibuprofen for closure of patent ductus arteriosus in preterm infants: a randomized controlled trial","volume":"32","author":"El-Farrash","year":"2019","unstructured":"11. El-Farrash RA, El Shimy MS, El-Sakka AS, Ahmed MG, Abdel-Moez DG. Efficacy and safety of oral paracetamol versus oral ibuprofen for closure of patent ductus arteriosus in preterm infants: a randomized controlled trial. J Matern Fetal Neonatal Med. 2019;32(21):3647-54.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"31","key":"key20211210131721_B12","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016689","article-title":"Oral ibuprofen is superior to oral paracetamol for patent ductus arteriosus in very low and extremely low birth weight infants","volume":"98","author":"Lu","year":"2019","unstructured":"12. Lu J, Li Q, Zhu L, Chen C, Li Z. Oral ibuprofen is superior to oral paracetamol for patent ductus arteriosus in very low and extremely low birth weight infants. Medicine (Baltimore). 2019;98(31):e16689.","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"key20211210131721_B13","doi-asserted-by":"crossref","DOI":"10.1111\/apa.13815","article-title":"Oral paracetamol or oral ibuprofen to close the ductus arteriosus: both \u2018work\u2019, but do we know when to use them?","volume":"106","author":"Ratcliffe","year":"2017","unstructured":"13. Ratcliffe SJ, Sherlock LG, Wright CJ. Oral paracetamol or oral ibuprofen to close the ductus arteriosus: both \u2018work\u2019, but do we know when to use them? Acta Paediatr. 2017;106(9):1539.","journal-title":"Acta Paediatr"},{"issue":"11","key":"key20211210131721_B14","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00431-015-2541-5","article-title":"Limited effects of intravenous paracetamol on patent ductus arteriosus in very low birth weight infants with contraindications for ibuprofen or after ibuprofen failure","volume":"174","author":"Roofthooft","year":"2015","unstructured":"14. Roofthooft DW, van Beynum IM, de Klerk JC, van Dijk M, van den Anker JN, Reiss IK, et al. Limited effects of intravenous paracetamol on patent ductus arteriosus in very low birth weight infants with contraindications for ibuprofen or after ibuprofen failure. Eur J Pediatr. 2015;174(11):1433-40.","journal-title":"Eur J Pediatr"},{"issue":"7","key":"key20211210131721_B15","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00431-016-2731-9","article-title":"Intravenous paracetamol for PDA closure in the preterm: a single-center experience","volume":"175","author":"Valerio","year":"2016","unstructured":"15. Valerio E, Valente MR, Salvadori S, Frigo AC, Baraldi E, Lago P. Intravenous paracetamol for PDA closure in the preterm: a single-center experience. Eur J Pediatr. 2016;175(7):953-66.","journal-title":"Eur J Pediatr"},{"key":"key20211210131721_B16","article-title":"Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants","volume":"1","author":"Ohlsson","year":"2020","unstructured":"16. Ohlsson A, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database Syst Rev. 2020;1:CD010061.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"key20211210131721_B17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/CMR.00031-13","article-title":"Early-onset neonatal sepsis","volume":"27","author":"Simonsen","year":"2014","unstructured":"17. Simonsen KA, Anderson-Berry AL, Delair SF, Davies HD. Early-onset neonatal sepsis. Clin Microbiol Rev. 2014;27(1):21-47.","journal-title":"Clin Microbiol Rev"},{"key":"key20211210131721_B18","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3985","article-title":"Incidence and Outcome of CPAP Failure in Preterm Infants","volume":"138","author":"Dargaville","year":"2016","unstructured":"18. Dargaville PA, Gerber A, Johansson S, De Paoli AG, Kamlin CO, Orsini F, et al. Incidence and Outcome of CPAP Failure in Preterm Infants. Pediatrics. 2016;138. pii: e20153985.","journal-title":"Pediatrics"},{"issue":"1","key":"key20211210131721_B19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0031-3955(16)34969-0","article-title":"Periventricular-intraventricular hemorrhage","volume":"33","author":"Allan","year":"1986","unstructured":"19. Allan WC, Volpe JJ. Periventricular-intraventricular hemorrhage. Pediatr Clin North Am. 1986;33(1):47-63.","journal-title":"Pediatr Clin North Am"},{"issue":"1","key":"key20211210131721_B20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000658-197801000-00001","article-title":"Neonatal necrotizing enterocolitis. Therapeutic decision based upon clinical staging","volume":"187","author":"Bell","year":"1978","unstructured":"20. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis. Therapeutic decision based upon clinical staging. An Surg. 1978;187(1):1\u20137.","journal-title":"An Surg"},{"issue":"6","key":"key20211210131721_B21","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.jp.7210963","article-title":"Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia","volume":"23","author":"Walsh","year":"2003","unstructured":"21. Walsh MC, Wilson-Costello D, Zadell A, Newman N, Fanaroff A. Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia. J Perinatol. 2003;23(6):451-6","journal-title":"J Perinatol"},{"issue":"7","key":"key20211210131721_B22","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The international classification of retinopathy of prematurity revisited","volume":"123","author":"International Committee for the Classification of Retinopathy of Prematurity","year":"2005","unstructured":"22. International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005;123(7):991-9.","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"key20211210131721_B23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000345337","article-title":"Intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants","volume":"103","author":"Oncel","year":"2013","unstructured":"23. Oncel MY, Yurttutan S, Degirmencioglu H, et al. Intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants. Neonatology. 2013;103(3):166-9.","journal-title":"Neonatology"},{"issue":"6","key":"key20211210131721_B24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1055\/s-0038-1673397","article-title":"A Mystery of Patent Ductus Arteriosus and Serum Osmolality in Preterm Infants","volume":"36","author":"Cakir","year":"2019","unstructured":"24. Cakir U, Tayman C. A Mystery of Patent Ductus Arteriosus and Serum Osmolality in Preterm Infants. Am J Perinatol. 2019;36(6):641-6.","journal-title":"Am J Perinatol"},{"issue":"6","key":"key20211210131721_B25","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3109\/14767058.2015.1029912","article-title":"Ductal closure with intravenous paracetamol: a new approach to patent ductus arteriosus treatment","volume":"29","author":"Memisoglu","year":"2016","unstructured":"25. Memisoglu A, Alp \u00dcnkar Z, Cetiner N, Akal\u0131n F, Ozdemir H, Bilgen HS, et al. Ductal closure with intravenous paracetamol: a new approach to patent ductus arteriosus treatment. J Matern Fetal Neonatal Med. 2016;29(6):987-90.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"key20211210131721_B26","doi-asserted-by":"crossref","DOI":"10.1136\/fn.82.3.F188","article-title":"Low superior vena cava flow and intraventricular haemorrhage in preterm infants","volume":"82","author":"Kluckow","year":"2000","unstructured":"26. Kluckow M, Evans N. Low superior vena cava flow and intraventricular haemorrhage in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2000;82(3):F188-94.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"5","key":"key20211210131721_B27","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1542\/peds.2009-3506","article-title":"Patent ductus arteriosus of the preterm infant","volume":"125","author":"Hamrick","year":"2010","unstructured":"27. Hamrick SE, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics. 2010;125(5):1020-30.","journal-title":"Pediatrics"},{"issue":"6","key":"key20211210131721_B28","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2011-0359","article-title":"Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment","volume":"128","author":"Hammerman","year":"2011","unstructured":"28. Hammerman C, Bin-Nun A, Markovitch E, Schimmel MS, Kaplan M, Fink D. Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment. Pediatrics. 2011;128(6):e1618-21.","journal-title":"Pediatrics"},{"issue":"10","key":"key20211210131721_B29","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/jp.2014.96","article-title":"Paracetamol treatment of patent ductus arteriosus in preterm infants","volume":"34","author":"Nadir","year":"2014","unstructured":"29. Nadir E, Kassem E, Foldi S, Hochberg A, Feldman M. Paracetamol treatment of patent ductus arteriosus in preterm infants. J Perinatol. 2014;34(10):748-9.","journal-title":"J Perinatol"},{"issue":"2","key":"key20211210131721_B30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/1060028014557564","article-title":"Acetaminophen for patent ductus arteriosus","volume":"49","author":"Le","year":"2015","unstructured":"30. Le J, Gales MA, Gales BJ. Acetaminophen for patent ductus arteriosus. Ann Pharmacother. 2015;49(2):241-6.","journal-title":"Ann Pharmacother"},{"issue":"6","key":"key20211210131721_B31","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/archdischild-2013-303688","article-title":"Paracetamol to induce ductus arteriosus closure: is it valid?","volume":"98","author":"Allegaert","year":"2013","unstructured":"31. Allegaert K, Anderson B, Simons S, van Overmeire B. Paracetamol to induce ductus arteriosus closure: is it valid? Arch Dis Child. 2013;98(6):462-6.","journal-title":"Arch Dis Child"},{"issue":"1","key":"key20211210131721_B32","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2012-302044","article-title":"An alternative drug (paracetamol) in the management of patent ductus arteriosus in ibuprofen-resistant or contraindicated preterm infants","volume":"98","author":"Oncel","year":"2013","unstructured":"32. Oncel MY, Yurttutan S, Uras N, Altug N, Ozdemir R, Ekmen S, et al. An alternative drug (paracetamol) in the management of patent ductus arteriosus in ibuprofen-resistant or contraindicated preterm infants. Arch Dis Child Fetal Neonatal Ed. 2013;98(1):F94.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"key20211210131721_B33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/2249-4847.109245","article-title":"An Interesting Observation of PDA Closure with Oral Paracetamol in Preterm Neonates","volume":"2","author":"Sinha","year":"2013","unstructured":"33. Sinha R, Negi V, Dalal SS. An Interesting Observation of PDA Closure with Oral Paracetamol in Preterm Neonates. J Clin Neonatol. 2013;2(1):30-2.","journal-title":"J Clin Neonatol"},{"issue":"2","key":"key20211210131721_B34","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00246-013-0770-9","article-title":"Paracetamol therapy for patent ductus arteriosus in premature infants: a chance before surgical ligation","volume":"35","author":"Ozdemir","year":"2014","unstructured":"34. Ozdemir OM, Do\u011fan M, K\u00fc\u00e7\u00fckta\u015f\u00e7\u0131 K, Ergin H, Sahin O. Paracetamol therapy for patent ductus arteriosus in premature infants: a chance before surgical ligation. Pediatr Cardiol. 2014;35(2):276-9.","journal-title":"Pediatr Cardiol"},{"issue":"2","key":"key20211210131721_B35","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1177\/0300060517722698","article-title":"Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus","volume":"46","author":"Al-Lawama","year":"2018","unstructured":"35. Al-Lawama M, Alammori I, Abdelghani T, Badran E. Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus. J Int Med Res. 2018;46(2):811-8.","journal-title":"J Int Med Res"},{"issue":"2","key":"key20211210131721_B36","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00246-017-1791-6","article-title":"Further Experience with Oral Paracetamol as a Rescue Therapy for Patent Ductus Arteriosus in Preterm Infants","volume":"39","author":"Sallmon","year":"2018","unstructured":"36. Sallmon H, Koehne P. Further Experience with Oral Paracetamol as a Rescue Therapy for Patent Ductus Arteriosus in Preterm Infants. Pediatr Cardiol. 2018;39(2):411-2.","journal-title":"Pediatr Cardiol"},{"issue":"1","key":"key20211210131721_B37","first-page":"52","article-title":"Pharmacotherapy for patent ductus arteriosus closure","volume":"14","author":"Ferguson","year":"2019","unstructured":"37. Ferguson JM. Pharmacotherapy for patent ductus arteriosus closure. Congenit Heart Dis. 2019;14(1):52-6.","journal-title":"Congenit Heart Dis"},{"issue":"4","key":"key20211210131721_B38","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00431-018-3086-1","article-title":"Effect on cerebral oxygenation of paracetamol for patent ductus arteriosus in preterm infants","volume":"177","author":"Dani","year":"2018","unstructured":"38. Dani C, Poggi C, Cianchi I, Corsini I, Vangi V, Pratesi S. Effect on cerebral oxygenation of paracetamol for patent ductus arteriosus in preterm infants. Eur J Pediatr. 2018;177(4):533-9.","journal-title":"Eur J Pediatr"}],"container-title":["Arquivos Brasileiros de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/abccardiol.org\/article\/qual-deve-ser-o-tratamento-de-primeira-linha-para-o-fechamento-de-persistencia-de-canal-arterial-hemodinamicamente-significativo-em-bebes-prematuros\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T13:07:12Z","timestamp":1747400832000},"score":1,"resource":{"primary":{"URL":"https:\/\/abccardiol.org\/article\/qual-deve-ser-o-tratamento-de-primeira-linha-para-o-fechamento-de-persistencia-de-canal-arterial-hemodinamicamente-significativo-em-bebes-prematuros\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,8]]},"references-count":38,"alternative-id":["10.36660\/abc.20201361"],"URL":"https:\/\/doi.org\/10.36660\/abc.20201361","relation":{},"ISSN":["0066-782X","1678-4170"],"issn-type":[{"value":"0066-782X","type":"print"},{"value":"1678-4170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,8]]}}}